The Atlanta Journal-Constitution

Vaccine distributi­on plan submitted to CDC

Health department emphasizes it’s still considered a first draft.

- By Helena Oliviero Helena. Oliviero@ ajc. com and ArielHarta­hart@ajc.com

DPH proposal lays groundwork for extraordin­ary undertakin­g to vaccinate millions statewide.

The Georgia Department of Public Health submitted its COVID- 19 vaccine distributi­on plan to the Centers for Disease Control and Prevention on Friday, laying the groundwork for an extraordin­ary undertakin­g to vaccinate millions of people across the state.

The 56- page plan touches on everything from ordering and tracking the vaccine to meeting cold- storage requiremen­ts. It also outlines a strategy of making the vaccine available at not only health care settings but nontraditi­onal places like churches and workplaces.

Even so, the plan lacks specifics. It doesn’t state exactly where all the vaccinatio­n sites will be. And it’s not clear how waivers will be granted for people who can’t afford the fees that clinics might charge for administer­ing the shots.

With vaccine supplies expected to be extremely limited in the initial months, it’s unknown how many doses will Georgia get. Experts say it’s not a simple population calculatio­n, and a vaccine won’t be done on a firstcome, first- served basis.

DPH emphasized the plan is still considered a first draft. The CDC will need to review it, and many details will need to be ironed out over the coming weeks. States across the country had to race to create their distributi­on plans by Friday, the deadline set by the federal government in August.

No one knows yet when, or even if, a vaccine will become available. Some experts have estimated that, for the general public, it will be the middle of next year at the earliest. It’s possible that a limited number of vaccines may be available by the end of the year for health careworker­s.

Thecountry has never had such an urgent demand to produce so many vaccine doses so quickly.

Every year, a flu vaccine is given to well over 100 million Americans. But COVID- 19 inoculatio­ns will be more complex because of the challenges of storage, delivery and tracking multiple vaccines with different requiremen­ts, said Julie Swann, a North Carolina State University professor who in 2009 served as a senior adviser to the CDC on the national distributi­on for the H1N1 flu vaccine.

Two leading vaccine candidates, by Moderna and Pfizer, use a new RNA technology and require ultralow temperatur­e storage. This will require a supply chain that can keep vaccines in tightly controlled temperatur­es from the moment they are made to the moment that they are administer­ed. Pfizer has devised “thermal boxes” that, unopened, can keep a batch of vaccines frozen for up to 10 days; once opened, though, they have to be replenishe­d with dry ice within 24hours.

Along with temperatur­e- controlled facilities, there also will be a need for monitoring capabiliti­es and trained staff. Because vaccines will be very valuable, security will be needed to prevent tampering and theft.

Another challenge: A vaccine will likely require two doses. That means doubling production and persuading people to return for the second shot. If multiple vaccines are available at the same time, health care providers will need to make sure that someone getting the first dose gets a second dose of the same vaccine.

The state plan noted many pharmacies and hospitals have systems they use for patient notificati­ons for appointmen­ts and for a medication pickup, and that they could use these same systems for second dose reminders to patients.

There also are questions about the cost of the vaccine for the public. Though the vaccines will arrive at clinics at no charge, the government is not going to pay for the vaccines to be administer­ed. To make money, clinics may still charge patients an administra­tive fee, which will have a limit of $ 43.86 for a twodose vaccine. The plan notes that clinics “must” waive the fee for those who can’t afford it, but it doesn’t say what that means, or how patients will know to ask for waivers. More than 1 million Georgians live below the poverty level.

 ?? JACK KEARSE/ EMORY UNIVERSITY ?? Jack Krost participat­es in phase 3 of the COVID- 19 vaccine trial at EmoryUnive­rsity’sHope Clinic. He’s with Laura Clegg, clinical research nurse at theHope Clinic.
JACK KEARSE/ EMORY UNIVERSITY Jack Krost participat­es in phase 3 of the COVID- 19 vaccine trial at EmoryUnive­rsity’sHope Clinic. He’s with Laura Clegg, clinical research nurse at theHope Clinic.

Newspapers in English

Newspapers from United States